Macasling, Walmar A.
HRN: 14-36-73 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2026
CEFTRIAXONE 1G (VIAL)
01/03/2026
01/09/2026
IV
1gm
Q12
T/c Acute Appendicitis
Checking Final Appropriateness
01/03/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/03/2026
01/09/2026
IV
500mg
Q8
Acute Appendicitis
Checking Final Appropriateness